Citius Pharmaceuticals annual free cash flow
2017
2020
2021
2024
2025
Citius Pharmaceuticals Free Cash Flow (FCF) History (CTXR)
Citius Pharmaceuticals reported −$32.3M in free cash flow for fiscal 2025, an increase of $898,637 from the previous fiscal year.
View full Citius Pharmaceuticals company overviewCitius Pharmaceuticals free cash flow by year
| Fiscal year | Period ended | Free cash flow | Change | Growth | FCF margin |
|---|---|---|---|---|---|
| 2025 | 2025-09-30 | −$32.3M | $898,637 | — | — |
| 2024 | 2024-09-30 | −$33.2M | — | — | — |
| 2021 | 2021-09-30 | −$24.3M | −$7.3M | — | −26952.61% |
| 2020 | 2020-09-30 | −$16.9M | — | — | −18813.88% |
| 2017 | 2017-09-30 | −$8.0M | — | — | −15946.66% |
Citius Pharmaceuticals quarterly free cash flow
Q1.26
Q2.26
| Fiscal quarter | Period ended | Free cash flow | Change | YoY growth | FCF margin |
|---|---|---|---|---|---|
| Q2 2026 | 2026-03-31 | −$1.9M | — | — | −113.96% |
| Q1 2026 | 2025-12-31 | −$17.4M | — | — | −441.39% |
Citius Pharmaceuticals free cash flow growth trends
Over the last five reported fiscal years, free cash flow declined from −$16.9M to −$32.3M, a net decrease of $15.4M. Citius Pharmaceuticals's latest reported quarter, Q2 2026, generated −$1.9M in free cash flow.
About the metric
What free cash flow means
Free cash flow is the cash a company generates from operations after capital expenditures. Positive FCF can fund dividends, buybacks, debt repayment, or reinvestment; negative FCF means capital spending exceeded operating cash flow for that period.
Calculation and source
How free cash flow is calculated
TickerStat calculates free cash flow as reported operating cash flow minus capital expenditures. FCF margin equals free cash flow divided by revenue. Fiscal periods can differ from calendar years, so the tables include exact period-end dates.
Review Citius Pharmaceuticals source filings ↗